Gaush Meditech (HKSE:02407) Cash-to-Debt : 1.25 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Gaush Meditech's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.25.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Gaush Meditech could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Gaush Meditech's Cash-to-Debt or its related term are showing as below:

HKSE:02407' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.28 Med: 1.08 Max: 8.76
Current: 1.25

During the past 5 years, Gaush Meditech's highest Cash to Debt Ratio was 8.76. The lowest was 0.28. And the median was 1.08.

HKSE:02407's Cash-to-Debt is ranked worse than
57.61% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs HKSE:02407: 1.25

Gaush Meditech Cash-to-Debt Historical Data

The historical data trend for Gaush Meditech's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Gaush Meditech Cash-to-Debt Chart

Gaush Meditech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

8.76

0.28

0.63

1.08

1.25

Gaush Meditech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			0.63	0.65	1.08	1.12	1.25

Competitive Comparison of Gaush Meditech's Cash-to-Debt

For the Medical Devices subindustry, Gaush Meditech's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gaush Meditech's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Cash-to-Debt falls into.

Gaush Meditech Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Gaush Meditech's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	911.159	/	(587.999	+	138.662)
	=	1.25

Gaush Meditech's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	911.159	/	(587.999	+	138.662)
	=	1.25

Gaush Meditech (HKSE:02407) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Gaush Meditech Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech (HKSE:02407) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN

Website

https://www.gaush.com

Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Gaush Meditech (HKSE:02407) Headlines

No Headlines